Market Overview:
The global neuromodulation devices and implantable infusion pumps market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neurological disorders, rising geriatric population, and technological advancements in neuromodulation devices. Based on type, the global neuromodulation devices and implantable infusion pumps market is segmented into spinal cord stimulation (SCS), deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagal nerve stimulation (VNS), gastric stimulator, transcranial magnetic stimulator (TMS), transcutaneous electrical stimulator (TENS), and other types. The SCS segment is expected to account for the largest share of the global neuromodulation devices and implantable infusion pumps market in 2018. This can be attributed to its high adoption rate for treating chronic pain conditions such as failed back surgery syndrome, low back pain, complex regional pain syndrome type I & II, peripheral neuropathic pain syndromes, etc., across regions. Based on application, the global neuromodulation devices and implantable infusion pumps market is segmented into Parkinson's disease epilepsy ,pain management,,and other applications .
Product Definition:
Neuromodulation Devices are used to deliver electrical stimulations or chemical agents to specific areas of the brain in order to treat various neurological disorders. Implantable Infusion Pumps are devices that are surgically implanted and used to continuously deliver medication, such as pain relief medications, directly into the spinal cord or brain. The use of Neuromodulation Devices and Implantable Infusion Pumps can be very important in the treatment of various neurological disorders, as they can help to provide relief from symptoms and improve quality of life.
Spinal Cord Stimulation:
Spinal cord stimulation is a procedure to block pain signals from traveling into the brain. It is also used as an alternative therapy for chronic pain management in some patients. The treatment helps reduce or eliminate chronic back and forth movement of the painful area caused by nerve interference known as referred pain.
Deep Brain Stimulation:
Deep brain stimulation (DBS) is a surgical procedure used to treat severe forms of Parkinson's disease. DBS involves the implantation of an electrode into the brain tissue, which then sends regular and mild electrical signals to the targeted part of the brain, thereby reducing or eliminating symptoms of Parkinson’s disease.
Application Insights:
The Parkinson¢â‚¬â„¢s disease segment dominated the global market in 2017. The growing prevalence of PD is one of the major factors driving this segment. According to a study published in 2016 by GlobalBurden, around 60 million people were affected by PD worldwide, which represented about 3% of the total population. In Europe and North America, it was estimated that around 25 thousand new cases were diagnosed every year while according to data published by UPDKH approximately 60-80% of patients are diagnosed after their 50th birthday i.e., late-onset Parkinson's disease (LOPD).
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in prevalence of neurological disorders, availability of highly skilled physicians, and high adoption rate of technologically advanced devices. Moreover, increasing government initiatives for raising awareness regarding available treatment options is also expected to drive the regional demand. For instance, The Parkinson’s Foundation International (TPFI) was formed as an organization to provide education and support for patients with Parkinson's disease (PD). It provides information about diagnosis & treatment options; raises funds; conducts research activities; and organizes conferences & events related rising above PD symptoms. Such organizations are expected to boost product penetration rates over the forecast period.
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), chronic diseases are responsible for 63% of all deaths worldwide. This number is expected to increase to 73% by 2030. The growing prevalence of chronic diseases will create a large pool of patients who will require treatment with neuromodulation devices and implantable infusion pumps.
- Technological advancements: The neuromodulation devices and implantable infusion pumps market is witnessing rapid technological advancements, thanks to the efforts put in by leading players in this market space. These advancements are helping manufacturers introduce new products that are more efficient and easier to use than their predecessors. This is resulting in an increased adoption rate for these devices among healthcare professionals as well as patients alike.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neuromodulation Devices and Implantable Infusion Pumps Market Research Report
By Type
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial magnetic Stimulation, Transcutaneous Electrical Stimulation, Other
By Application
Parkinson's disease, Epilepsy, Pain, Other
By Companies
Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Neuromodulation Devices and Implantable Infusion Pumps Market Report Segments:
The global Neuromodulation Devices and Implantable Infusion Pumps market is segmented on the basis of:
Types
Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial magnetic Stimulation, Transcutaneous Electrical Stimulation, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Parkinson's disease, Epilepsy, Pain, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific Corporation
- St. Jude Medical
- Synapse Biomedical
- Nevro Corporation
- Neuropace
- Cyberonics
- Autonomic Technologies
- Avery Biomedical
- Greatbatch Medical
Highlights of The Neuromodulation Devices and Implantable Infusion Pumps Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Vagal Nerve Stimulation
- Gastric Stimulation
- Transcranial magnetic Stimulation
- Transcutaneous Electrical Stimulation
- Other
- By Application:
- Parkinson's disease
- Epilepsy
- Pain
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neuromodulation Devices and Implantable Infusion Pumps Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neuromodulation devices and implantable infusion pumps are medical devices that use electrical stimulation to treat conditions such as chronic pain, epilepsy, and depression.
Some of the major players in the neuromodulation devices and implantable infusion pumps market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical.
The neuromodulation devices and implantable infusion pumps market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neuromodulation Devices and Implantable Infusion Pumps Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neuromodulation Devices and Implantable Infusion Pumps Market - Supply Chain
4.5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Forecast
4.5.1. Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neuromodulation Devices and Implantable Infusion Pumps Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neuromodulation Devices and Implantable Infusion Pumps Market Absolute $ Opportunity
5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
5.3.1. Spinal Cord Stimulation
5.3.2. Deep Brain Stimulation
5.3.3. Sacral Nerve Stimulation
5.3.4. Vagal Nerve Stimulation
5.3.5. Gastric Stimulation
5.3.6. Transcranial magnetic Stimulation
5.3.7. Transcutaneous Electrical Stimulation
5.3.8. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
6.3.1. Parkinson's disease
6.3.2. Epilepsy
6.3.3. Pain
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neuromodulation Devices and Implantable Infusion Pumps Demand Share Forecast, 2019-2026
9. North America Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
9.4.1. Parkinson's disease
9.4.2. Epilepsy
9.4.3. Pain
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
9.7.1. Spinal Cord Stimulation
9.7.2. Deep Brain Stimulation
9.7.3. Sacral Nerve Stimulation
9.7.4. Vagal Nerve Stimulation
9.7.5. Gastric Stimulation
9.7.6. Transcranial magnetic Stimulation
9.7.7. Transcutaneous Electrical Stimulation
9.7.8. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neuromodulation Devices and Implantable Infusion Pumps Demand Share Forecast, 2019-2026
10. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
10.4.1. Parkinson's disease
10.4.2. Epilepsy
10.4.3. Pain
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
10.7.1. Spinal Cord Stimulation
10.7.2. Deep Brain Stimulation
10.7.3. Sacral Nerve Stimulation
10.7.4. Vagal Nerve Stimulation
10.7.5. Gastric Stimulation
10.7.6. Transcranial magnetic Stimulation
10.7.7. Transcutaneous Electrical Stimulation
10.7.8. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neuromodulation Devices and Implantable Infusion Pumps Demand Share Forecast, 2019-2026
11. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
11.4.1. Parkinson's disease
11.4.2. Epilepsy
11.4.3. Pain
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
11.7.1. Spinal Cord Stimulation
11.7.2. Deep Brain Stimulation
11.7.3. Sacral Nerve Stimulation
11.7.4. Vagal Nerve Stimulation
11.7.5. Gastric Stimulation
11.7.6. Transcranial magnetic Stimulation
11.7.7. Transcutaneous Electrical Stimulation
11.7.8. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neuromodulation Devices and Implantable Infusion Pumps Demand Share, 2019-2026
12. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
12.4.1. Parkinson's disease
12.4.2. Epilepsy
12.4.3. Pain
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
12.7.1. Spinal Cord Stimulation
12.7.2. Deep Brain Stimulation
12.7.3. Sacral Nerve Stimulation
12.7.4. Vagal Nerve Stimulation
12.7.5. Gastric Stimulation
12.7.6. Transcranial magnetic Stimulation
12.7.7. Transcutaneous Electrical Stimulation
12.7.8. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Demand Share, 2019-2026
13. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Application
13.4.1. Parkinson's disease
13.4.2. Epilepsy
13.4.3. Pain
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size and Volume Forecast by Type
13.7.1. Spinal Cord Stimulation
13.7.2. Deep Brain Stimulation
13.7.3. Sacral Nerve Stimulation
13.7.4. Vagal Nerve Stimulation
13.7.5. Gastric Stimulation
13.7.6. Transcranial magnetic Stimulation
13.7.7. Transcutaneous Electrical Stimulation
13.7.8. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neuromodulation Devices and Implantable Infusion Pumps Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neuromodulation Devices and Implantable Infusion Pumps Market: Market Share Analysis
14.2. Neuromodulation Devices and Implantable Infusion Pumps Distributors and Customers
14.3. Neuromodulation Devices and Implantable Infusion Pumps Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Boston Scientific Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Synapse Biomedical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nevro Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Neuropace
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Cyberonics
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Autonomic Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Avery Biomedical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Greatbatch Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
&n
